Chemicals Firm Tatva Chintan to Source 6.4 MW of Wind-Solar Power from AMPIN

The company will acquire a 10.99% stake in AMPIN’s SPV

February 19, 2026

/ Melvin Mathew
/ Open Access, Solar, Wind
thumbnail

Follow Mercom India on WhatsApp for exclusive updates on clean energy news and insights


Chemical manufacturing company Tatva Chintan Pharma Chem has signed agreements to procure 6.4 MW of power from AMPIN C&I Power Twenty Six’s (AMPIN) 19.8 MW wind-solar hybrid group captive project in Gujarat.

MERCOM Insider

Where clean energy's most influential leaders get their intelligence

Exclusive reporting, market intelligence, and insider access that shapes billion-dollar decisions in renewable energy and clean technology.

Already have an account? Sign In

Register for free

thumbnail

Melvin Mathew

More articles from Melvin Mathew.
AmpIn Energy TransitionGroup CaptiveSolarTatva Chintan Pharma Chemwind
PREVALL POSTSNEXT

RELATED POSTS

Get the most relevant India solar and clean energy news.

RECENT POSTS